First patient in Malaysia successfully treated with Urolastic™ – collaboration between Leader Biomedical and Urogyn yields first results

26 September 2017- AMSTERDAM | MALAYSIA- Urogyn B.V. and Leader Biomedical announce the first patient treated in Malaysia with Urolastic™– an innovative Urinary Stress Incontinence product that is exclusively offered by Leader Biomedical in India and APAC.

We are excited to announce that we have successfully introduced Urolastic™ in Malaysia and treated a female patient suffering from severe Stress Urinary Incontinence (SUI). The patient suffered from the condition, as a result of birth deficiencies and was diagnosed with a short, yet very wide urethra. After previously undergoing a procedure using a bulking agent, the patient went down from using eight pads a day, to five pads a day. Treatment with Urolastic™ earlier this month by Dr. Warren Lo Hwa Loon at Pantai Hospital Kuala Lumpur has improved the patient’s condition, as a result of which she now only uses one pad a day, thus significantly improving her quality of life.

Stress Urinary Incontinence is a disease affecting over 200 million people worldwide. Traditionally, SUI is treated with either a sling or injection of a bulking agent, where a sling procedure is an invasive procedure for the patient and the traditional bulking agents are expensive, as they are only effective for a short period and need to be repeated regularly.

“Patients who would benefit from bulking agent procedure are those that suffered from a failed sling procedure, elderly patients that are happy with a positive effect and incontinence reduction rather than a guaranteed total stop of leakage, and patients that prefer minimally-invasive surgery as opposed to sling procedure surgery” shares Dr. Warren Lo Hwa Loon, Pantai Hospital Kuala Lumpur.

“Urolastic™ is the most effective bulking agent available to patients suffering from SUI. The agent stays at the application site since it is not a fluid in the body, but hardens to form a solid mass. Also, treatment with Urolastic™ is an outpatient procedure in most cases. In addition to being an attractive procedure for the elderly and after failed sling procedures, it also provides an alternative for women who still wish to have children”, adds Dr. Pieter Venema, urologist and experienced Urogyn trainer from the Netherlands.

READ MORE ON: www.leaderbiomedical.com

NIEUWS

Urogyn op de 50Plus beurs: 19 t/m 23 september 2017 Jaarbeurs Utrecht

Op deze feestelijke editie van de 50PlusBeurs is ook Urogyn aanwezig.

Bij onze stand in Hal 9 kunt u meer informatie krijgen over onze producten om stressincontinentie te behandelen, voor zowel mannen als vrouwen.

Wist u dat ongewenst urineverlies een veelvoorkomende aandoening is? Ongeveer één op de drie vrouwen en één op de tien mannen van 55 jaar en ouder hebben hier last van. Ongewenst urineverlies kan een ingrijpend effect hebben op de kwaliteit van leven. Het kan schaamte teweegbrengen, stress, frustratie, verlies van eigenwaarde en depressieve gevoelens, en zorgt voor beperkingen in de dagelijkste activiteiten en de seksualiteit. Slechts een minderheid zoekt hulp bij ongewenst urineverlies, terwijl het goed te behandelen is. Wilt u ook weer activiteiten ondernemen zonder zorgen over ongewenst urineverlies? Kom dan zeker even langs onze stand op de beurs voor meer informatie.
In 25 jaar is de 50PlusBeurs met 600 exposanten en 100.000 bezoekers uitgegroeid tot ’s werelds grootste evenement voor actieve plussers. Dat was bij de eerste editie wel anders. In Den Haag kwamen toen 96 exposanten en bijna 9.000 bezoekers bijeen. 50Plus was toen niet hip en klonk erg oud. Nu is dat veranderd. We vieren het leven en alles wat het leven je biedt.

Op de 50PlusBeurs is voor elk wat wils, voor het gemak is de beurs onderverdeeld in de volgende thema’s:
• Vakantie
• Vrije tijd
• Wonen
• Mode & Beauty
• Gezondheid
• Maatschappij

In ieder thema zijn stands boordevol informatie, amusement en voordeel te vinden. Verder zijn er nog workshops en presentaties, vele optredens op podia met muziek, modeshows, kookdemonstraties, dans en theater. Even een rustmomentje tijdens uw beursbezoek? Daarvoor is er ook in iedere hal een speciaal thematerras, waar u rustig kunt zitten en waar ook eten en drinken te verkrijgen is.

Met de speciale Silver Edition viert de 50PlusBeurs dit zilveren jubileum. Speciaal vanwege de 25e editie krijgt iedere bezoeker een Silver Surprise en zijn er speciale activiteiten. Zo is er voor de sportieve plussers een recordpoging, Silver Challenge, waarbij de beurs met meer dan 1.000 plussers sportief geopend wordt. Voor de vrolijke, verzorgde en modieuze plusser is er een Silver Model Verkiezing, waarvan de finale tijdens de 50PlusBeurs plaats zal vinden. Daarnaast is er direct ná de beurs nog een Silver Show, een feestelijke voorstelling met zang en cabaret met het leven als onuitputtelijke bron van inspiratie.
Al met al is er meer dan voldoende te beleven op de grootste beurs voor actieve plussers.

De 25e editie van de 50PlusBeurs is van 19 t/m 23 september in de Jaarbeurs Utrecht. Dagelijks open van 10.00 tot 17.00 uur.

NIEUWS

Ready for the start of the International Continence Society Meeting in Florence!

We are at the International Continence Society Meeting which is taking place between 12th to 15th September in Florence, Italy. You can find us at booth 34 to learn more about our products for treating stress urinary incontinence, Urolastic and Prolastic.

Meet us there or send us an e-mail at info@urogynbv.com in order to set up a meeting with one of our representatives at the meeting.

NIEUWS

We would like to welcome ELVIM LTD to our growing list of distributors

We are very happy to announce that our products will soon be available in Estonia, Latvia and Lithuania thanks to our new distributor, ELVIM LTD.

ELVIM is a GDP licensed medicines wholesaler established in 1992 in Riga, Latvia. ELVIM offers marketing and distribution of medicines and medical devices in the Baltic countries and CIS countries, and provides related services.

Today we welcomed the first two specialists from Latvia at a Urolastic training session in the LangeLand Hospital in Zoetermeer, The Netherlands and we are very hopeful that the first Urolastic procedures in Latvia will be performed before the end of this year.

For more information regarding the availability of Urogyn products in Estonia, Latvia and Lithuania, please contact ELVIM by e-mail: hq@elvim.lv or visit www.elvim.lv

NIEUWS

Learn more about our products by visiting us at booth 34 during the ICS 2017

We are pleased to announce that we will be present at the 47th Annual Meeting of the International Continence Society in Florence, Italy from 12th-15th September 2017.
The meeting is multidisciplinary, bringing together all the professionals working in the field: urologists, gynaecologists, neurologists, physiotherapists, nurses, midwives and basic scientists.
If you are visiting the congress you will be able to learn more about Urogyn and our products at booth number 34.
We will also provide information regarding ongoing clinical trials and training opportunities for specialists.

For more information regarding the congress please visit: www.ics.org

NIEUWS

Urogyn op N1, zaterdag 08 juli (18:00 uur)

Urogyn is op 8 juli aanwezig in de uitzending van NIJMEEGSE KENNIS op N1.
Noes de Vries (CEO) wordt geïnterviewd door Guido Matthee over stressincontinentie bij vrouwen. Tijdens het interview gaat Noes in op de behandeling en werking van Urolastic.
Een interessant interview voor iedereen die op zoek is naar een langdurige, niet-operatieve oplossing bij stressincontinentie.

Waar en wanneer kunt u deze uitzending bekijken:
Uitzending op N1: zaterdag 08 juli (18:00 uur)
Daarna wordt de uitzending ieder uur herhaald.
Herhaling op N1: woensdag 12 juli (17:00 uur)
Voor iedereen buiten de regio Nijmegen is de uitzending vanaf donderdag 13 juli ook te zien via YouTube. De exacte link zal ook op de Urogyn website geplaatst worden.

NIEUWS

Dr. John Heesakkers from the Radboud University Medical Centre provides training for specialists from Czech Republic

Doctors from Czech Republic attended training at the Radboud University Medical Centre in Nijmegen, Netherlands today.
Two patients were treated by Dr. Heesakkers and doctors were able to view the procedures as well as participate in practical demonstrations given by the Urogyn team.

For more information regarding training in The Netherlands, contact us at info@urogynbv.com

NIEUWSNIEUWS

Training in the Urolastic procedure provided for doctors from Croatia and Bosnia and Herzegovina

Thirty doctors from Croatia and Bosnia and Herzegovina attended the Urolastic workshop organized by our distributors Elva Pharma, on the 5th May2017 in Opatija, Croatia.
The training was performed by Dr. Mija Blaganje, urogynaecologist at the Ljubljana University Medical Centre in Slovenia and Dr. Pieter Minnee, urologist at The Lange Land hospital in The Netherlands.
The training program included lectures by our expert practitioners on how to apply Urolastic and the benefits of choosing this procedure for treating patients with stress urinary incontinence. In addition, participants were given practical demonstrations of the Urolastic procedure. We are happy to announce the workshop was a success and are looking forward to future workshops in Croatia.
More information about Urolastic workshops organized in Croatia can be found by contacting our distributors at: info@elvapharma.com

NIEUWS

Urogyn binnenkort te zien op N1

Afgelopen week was N1 (regionale zender) op bezoek bij Urogyn om opnames te maken voor het nieuwe programma NIJMEEGSE KENNIS. In het programma wordt op zoek gegaan naar innovatieve ontwikkelingen en producten met een Nijmeegse oorsprong. In de serie van 7 of 8 innovaties laat Nijmeegse Kennis zien dat er hele interessante dingen gebeuren in Nijmegen.
Eén van de innovatieve producten in de serie is Urolastic, de niet-operatieve behandeling van stressincontinentie bij vrouwen. De serie zal worden uitgezonden in maart en april op N1. Wanneer de exacte datum en tijd van de uitzending van Urolastic bekend zijn, zullen we dat hier bekend maken.

NIEUWS

Leader Biomedical and Urogyn collaborate to bring innovative new procedure Urolastic™ to India

Amsterdam, The Netherlands- Urogyn B.V. and Leader Biomedical are proud to announce that Urolastic™ – an innovative Urinary Stress incontinence product – has been introduced into the product registration process in India. This marks the first step towards bringing a novel therapeutic solution to patients and caregivers in India.

Many women suffer from Stress Urinary Incontinence (SUI), radically affecting their quality of life due to restraining problems. Their social life is negatively influenced by involuntary leakage during coughing, sneezing, laughing or exercise. Urogyn has developed a product that shares the properties of being injectable, but does not shrink or degrade, thus remaining effective in the longer term. The material will also show up on X-rays and ultrasound, and can be removed if required.

Urolastic™ is an extremely biocompatible rubbery compound that forms in place after injection. The product consists of a dual syringe that is connected to a static mixing tube with a needle. When the dual syringe is compressed, the two components meet and mix in the static mixing tube. The mixed compound is then passed through the needle. This permits small amounts of compound to be placed in the tissue around the urethra. The mixture forms as small flexible balls, which are over time encapsulated in scar tissue.

“Urogyn B.V. has developed a unique, innovative, cost effective, and above all, female friendly procedure for the treatment of urinary incontinence in women. Our product Urolastic™ provides a minimally-invasive treatment, which is performed under local anesthesia and delivers long-lasting improvements to the quality of life of the patient. Through our new partnership with Leader Biomedical we are able to bring this state of the art treatment for Urinary Stress incontinence to the Indian market.” says Martijn Ligtenberg, COO/CFO, Urogyn B.V.

“The collaboration with Urogyn allows us to further increase our downstream value chain and supports our vision to continuously improve global access to next generation healthcare to India. We see great promise for this product here and we are diligently evaluating opportunities to carry the product in the Leader Biomedical network globally. As part of this larger goal, the product is expected to be introduced in India in the lag end of FY 2017”, adds Basil Babychan, Business Director, Leader Biomedical Group.

About Urogyn: Urogyn was founded in 2009 with the ambition of developing new products in the field of urology and gynaecology, based upon a two-component polymer technology. The first products are now used in the treatment of Stress Urinary Incontinence (SUI) for both men and women. More products are expected to be commercially launched in the near future for birth control and treating faecal incontinence (www.urogynbv.com).

About Leader Biomedical: Leader Biomedical seeks to become a leader in the supply of biomaterials and surgical implants, improving global markets’ access to next generation technologies, and medical devices (www.leaderbiomedical.com).

NIEUWS

Urogyn present at the first scientific meeting of The Parisian Institute of the Pelvic floor & Incontinence

The Parisian Institute of Pelvic floor & Incontinence, organizes its first scientific meeting on Saturday 7 January 2017 at the Royal Pavilion in Paris.

The “Parisian Institute of Pelvic floor & Incontinence” is a health association whose main objective is the multidisciplinary management of pelvic floor disorders, health and quality of life of women.

The scientific program covers the treatment of female urinary incontinence, from diagnosis to treatment.

Innovative new techniques and projects will be presented by the speakers and doctors can visit the Urogyn booth where they will be able to see our incontinence products and sign up for training sessions.

NIEUWS

Welkom op onze nieuwe website!

We zijn verheugd de lancering van onze nieuwe website aan te kondigen. We hopen dat dit nieuwe ontwerp het makkelijker en sneller voor u maakt de juiste informatie te vinden.
Onze site wordt regelmatig aangevuld met bruikbare informatie en nieuws, dus we zien u graag weer terug om u op de hoogte te houden.
Indien U meer informatie wenst, kunt u contact opnemen via info@urogynbv.com

NIEUWS

Elva Pharma, our new partner in Croatia!

We are pleased to announce that we have entered into an agreement with Elva Pharma which makes them our exclusive distributor in Croatia.
Elva pharma offers the broad knowledge base of highly experienced, “big pharma” trained professionals, which covers all aspects of the pharmaceutical value chain.
We look forward to working with them and supporting them in bringing our innovative products to the Croatian market.
For further information, please visit their website: www.elvapharma.com

NIEUWS

Our products soon available in Colombia

To support our growing list of worldwide distributors, we have appointed the company Gilmedica SA to distribute our products in Colombia.

Gilmedica  is a Colombian company, whose headquarters is located in Acopi Yumbo and has commercial and technical offices in major cities throughout the country, dedicated to importing, marketing and distribution of medical devices and equipment, with more than 36 years of experience in the sector.

To find out more please visit their website www.gilmedica.com

NIEUWS

New distributor announcement in Slovakia and Czech Republic

Urogyn is pleased to announce that we have signed an agreement with Archie Samuel s.r.o. to have appointed them as our exclusive distributor for Czech Republic and Slovakia. Established in 1995, the company is specialized in services for the health care industry with a focus on distribution of urology, uro-gynaecology and onco-urology products.

We welcome Archie Samuel s.r.o. to our international distributor network and look forward to a fruitful collaboration.